FutureNeuro Header image

FutureNeuro hosts national clinical conference on
Neurological disease

Clinicians, scientists and patient representatives to focus on epilepsy and Motor Neuron disease

Friday, 26 October 2018: FutureNeuro, the SFI Research Centre for chronic and rare neurological disease, will hold its inaugural national clinical conference today at RCSI. The event will focus on translating neurological research, on epilepsy and Motor Neuron disease, into clinical care for patients.

The conference brings together clinical neurologists from Irish hospitals, neuroscientists and patient representative organisations for neurological conditions.

Professor David Henshall, Director of FutureNeuro and Professor of Molecular Physiology and Neuroscience at RCSI said: “FutureNeuro recognises the strategic importance of clinicians, and the patients they support, in maximising the impact of a centre dedicated to advancing research into chronic and rare neurological disease. This first clinical conference is designed to strengthen the partnership between the research and clinical networks to ensure better patient outcomes”.

Among those addressing the conference are international keynote speakers, who are recognised as world-leaders in the fields of neuroscience.

Dame Professor Pamela Shaw, Consultant Neurologist, Sheffield Teaching Hospitals & Professor of Neurology, University of Sheffield will deliver a plenary lecture on the topic “Translational neuroscience to improve outcomes for Motor Neuron disease. Are we winning?”

Professor Dimitri Kullmann, Professor of Neurology-Clinical & Experimental Epilepsy, University College London will give a keynhote address on the topic “Gene therapy for refractory epilepsy – how far from the clinic?”

The theme of the conference is “Translating Neurological Research into Service Delivery”. Throughout the day, talks will address the three research pillars of the FutureNeuro Centre: diagnostics, therapeutics and eHealth. Other topics covered by FutureNeuro scientists and clinicians include genomics as a diagnostics tool; patient health records to support better clinical outcomes; and the long-term view for epilepsy and Motor Neuron disease research.

The overall aim of the conference is to ensure that the network of clinicians associated with FutureNeuro can maximise the value of the neurological research coming out of the centre and bring it in to their clinical practice. Delegates will have the opportunity to learn about FutureNeuro’s strategy and key neurological research advancements to enable them to provide clinical input to the Centre’s planned research activities.

ENDS

About FutureNeuro
FutureNeuro is a new SFI Research Centre dedicated to developing new technologies and solutions for the treatment, diagnosis, and monitoring of chronic and rare neurological diseases. It is supported by Science Foundation Ireland. Initially focusing on Epilepsy and Motor Neuron Disease, FutureNeuro will build rapidly to help transform the lives of the approximately 700,000 people affected by neurological disorders in Ireland.

It connects national and multinational industry with key academics and clinicians based in our leading hospitals to provide diagnostic, therapeutic and E-Health solutions. FutureNeuro’s projects with industry partners will bring diagnostic supports to market, a pipeline of new drugs, and connected health solutions that enable patients to monitor and report their health better than ever before.
futureneurocentre.ie